FLR 10-Q
Fluor Corp (FLR)
10-Q
2023-11-03
For: 2023-09-30
View Original
Added on
April 08, 2026
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
For the quarterly period ended September 30, 2023
Or
For the transition period from to
Commission File Number: 1-16129
(Exact name of registrant as specified in its charter)
| (State or other jurisdiction of | (I.R.S. Employer | ||||||||||
| incorporation or organization) | Identification No.) | ||||||||||
| (Address of principal executive offices) | (Zip Code) | ||||||||||
(Registrant’s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
| Title of Each Class | Trading Symbol(s) | Name of Each Exchange on Which Registered | ||||||
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ý No o
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ý No o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):
| ☒ | Accelerated filer | ☐ | |||||||||
| Non-accelerated filer | ☐ | Smaller reporting company | |||||||||
| Emerging growth company | |||||||||||
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ý
As of October 31, 2023, 170,375,090 shares of the registrant’s common stock, $0.01 par value, were outstanding.
FLUOR CORPORATION
FORM 10-Q
| TABLE OF CONTENTS | PAGE | ||||||||||
1
Glossary of Terms
The definitions and abbreviations set forth below apply to the indicated terms used throughout this filing.
| Abbreviation/Term | Definition | ||||
| 2022 10-K | Annual Report on Form 10-K for the year ended December 31, 2022 | ||||
| 2022 Period | Nine months ended September 30, 2022 | ||||
| 2022 Quarter | Three months ended September 30, 2022 | ||||
| 2023 Period | Nine months ended September 30, 2023 | ||||
| 2023 Quarter | Three months ended September 30, 2023 | ||||
| 3ME | Three months ended | ||||
| 9ME | Nine months ended | ||||
| AMECO | American Equipment Company, Inc. | ||||
| AOCI | Accumulated other comprehensive income (loss) | ||||
| APIC | Additional paid-in capital | ||||
| ASC | Accounting Standards Codification | ||||
| ASU | Accounting Standards Update | ||||
| ATLS | Advanced technologies & life sciences | ||||
| CFM | Customer-furnished materials | ||||
| COVID | Coronavirus pandemic | ||||
| CPS | Convertible preferred stock | ||||
| CTA | Currency translation adjustment | ||||
| DB plan | Defined benefit pension plan | ||||
| DOE | U.S. Department of Energy | ||||
| DOJ | U.S. Department of Justice | ||||
| EPC | Engineering, procurement and construction | ||||
| EPS | Earnings (loss) per share | ||||
| Exchange Act | Securities Exchange Act of 1934 | ||||
| Fluor | Fluor Corporation | ||||
| G&A | General and administrative expense | ||||
| GAAP | Accounting principles generally accepted in the United States | ||||
| ICFR | Internal control over financial reporting | ||||
| IT | Information technology | ||||
| LNG | Liquefied natural gas | ||||
| NCI | Noncontrolling interests | ||||
| NM | Not meaningful | ||||
| NuScale | NuScale Power, LLC | ||||
| OCI | Other comprehensive income (loss) | ||||
| PP&E | Property, plant and equipment | ||||
| RSU | Restricted stock units | ||||
| RUPO | Remaining unsatisfied performance obligations | ||||
| SEC | Securities and Exchange Commission | ||||
| SGI | Stock growth incentive awards | ||||
| SMR | Small modular reactor | ||||
| Stork | Stork Holding B.V. and subsidiaries | ||||
| TSR | Total shareholder return | ||||
| VIE | Variable interest entity | ||||
2
PART I: FINANCIAL INFORMATION
Item 1. Financial Statements
FLUOR CORPORATION
CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS
UNAUDITED
| 3ME September 30, | 9ME September 30, | ||||||||||||||||||||||
| (in millions, except per share amounts) | 2023 | 2022 | 2023 | 2022 | |||||||||||||||||||
| Revenue | $ | $ | $ | $ | |||||||||||||||||||
| Cost of revenue | ( | ( | ( | ( | |||||||||||||||||||
| Gross profit (loss) | ( | ||||||||||||||||||||||
| G&A | ( | ( | ( | ( | |||||||||||||||||||
| Impairment | |||||||||||||||||||||||
| Foreign currency gain (loss) | ( | ||||||||||||||||||||||
| Operating profit (loss) | ( | ||||||||||||||||||||||
| Interest expense | ( | ( | ( | ( | |||||||||||||||||||
| Interest income | |||||||||||||||||||||||
| Earnings before taxes | |||||||||||||||||||||||
| Income tax expense | ( | ( | ( | ( | |||||||||||||||||||
| Net earnings (loss) | ( | ||||||||||||||||||||||
| Less: Net earnings (loss) attributable to NCI | ( | ( | ( | ( | |||||||||||||||||||
Net earnings attributable to Fluor | $ | $ | $ | $ | |||||||||||||||||||
| Less: Dividends on CPS | |||||||||||||||||||||||
Less: Make-whole payment on conversion of CPS | |||||||||||||||||||||||
Net earnings available to Fluor common stockholders | $ | $ | $ | $ | |||||||||||||||||||
| Basic EPS available to Fluor common stockholders | $ | $ | $ | $ | |||||||||||||||||||
| Diluted EPS available to Fluor common stockholders | |||||||||||||||||||||||
The accompanying notes are an integral part of these financial statements.
3
FLUOR CORPORATION
CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME (LOSS)
UNAUDITED
| 3ME September 30, | 9ME September 30, | |||||||||||||||||||||||||
| (in millions) | 2023 | 2022 | 2023 | 2022 | ||||||||||||||||||||||
| Net earnings (loss) | $ | $ | ( | $ | $ | |||||||||||||||||||||
| OCI, net of tax: | ||||||||||||||||||||||||||
| Foreign currency translation adjustment | ( | ( | ( | |||||||||||||||||||||||
| Ownership share of equity method investees’ OCI | ( | |||||||||||||||||||||||||
| Other | ( | ( | ( | |||||||||||||||||||||||
| Total OCI, net of tax | ( | ( | ( | |||||||||||||||||||||||
| Comprehensive income (loss) | ( | |||||||||||||||||||||||||
| Less: Comprehensive income (loss) attributable to NCI | ( | ( | ( | ( | ||||||||||||||||||||||
| Comprehensive income (loss) attributable to Fluor | $ | $ | ( | $ | $ | |||||||||||||||||||||
The accompanying notes are an integral part of these financial statements.
4
FLUOR CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEET
UNAUDITED
| (in millions, except share and per share amounts) | September 30, 2023 | December 31, 2022 | ||||||||||||
| ASSETS | ||||||||||||||
| Current assets | ||||||||||||||
Cash and cash equivalents ($ | $ | $ | ||||||||||||
Marketable securities ($ | ||||||||||||||
Accounts receivable, net ($ | ||||||||||||||
Contract assets ($ | ||||||||||||||
Other current assets ($ | ||||||||||||||
| Total current assets | ||||||||||||||
| Noncurrent assets | ||||||||||||||
Marketable securities, noncurrent | ||||||||||||||
Property, plant and equipment, net ($ | ||||||||||||||
| Investments | ||||||||||||||
| Deferred taxes | ||||||||||||||
| Deferred compensation trusts | ||||||||||||||
| Goodwill | ||||||||||||||
Other assets ($ | ||||||||||||||
| Total noncurrent assets | ||||||||||||||
| Total assets | $ | $ | ||||||||||||
| LIABILITIES AND EQUITY | ||||||||||||||
| Current liabilities | ||||||||||||||
Accounts payable ($ | $ | $ | ||||||||||||
| Short-term debt and current portion of long-term debt | ||||||||||||||
Contract liabilities ($ | ||||||||||||||
Accrued salaries, wages and benefits ($ | ||||||||||||||
Other accrued liabilities ($ | ||||||||||||||
| Total current liabilities | ||||||||||||||
| Long-term debt | ||||||||||||||
| Deferred taxes | ||||||||||||||
Other noncurrent liabilities ($ | ||||||||||||||
| Commitments and contingencies | ||||||||||||||
| Equity | ||||||||||||||
| Shareholders’ equity | ||||||||||||||
Preferred stock — authorized | ||||||||||||||
Common stock — authorized | ||||||||||||||
APIC | ||||||||||||||
| AOCI | ( | ( | ||||||||||||
| Retained earnings | ||||||||||||||
| Total shareholders’ equity | ||||||||||||||
| NCI | ||||||||||||||
| Total equity | ||||||||||||||
| Total liabilities and equity | $ | $ | ||||||||||||
The accompanying notes are an integral part of these financial statements.
5
FLUOR CORPORATION
CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS
UNAUDITED
| 9ME September 30, | ||||||||||||||
| (in millions) | 2023 | 2022 | ||||||||||||
| OPERATING CASH FLOW | ||||||||||||||
Net earnings | $ | $ | ||||||||||||
Adjustments to reconcile net earnings to operating cash flow: | ||||||||||||||
| Impairment | ( | |||||||||||||
| Depreciation and amortization | ||||||||||||||
| (Earnings) loss from equity method investments, net of distributions | ( | ( | ||||||||||||
| (Gain) loss on sales of assets (including AMECO-South America in 2023) | ( | |||||||||||||
| Stock-based compensation | ||||||||||||||
| Deferred taxes | ( | ( | ||||||||||||
| Changes in assets and liabilities | ( | ( | ||||||||||||
| Other | ( | ( | ||||||||||||
| Operating cash flow | ( | ( | ||||||||||||
| INVESTING CASH FLOW | ||||||||||||||
| Purchases of marketable securities | ( | ( | ||||||||||||
| Proceeds from sales and maturities of marketable securities | ||||||||||||||
| Capital expenditures | ( | ( | ||||||||||||
| Proceeds from sales of assets (including AMECO-South America in 2023) | ||||||||||||||
| Investments in partnerships and joint ventures | ( | ( | ||||||||||||
| Other | ||||||||||||||
| Investing cash flow | ( | ( | ||||||||||||
| FINANCING CASH FLOW | ||||||||||||||
Proceeds from issuance of 2029 Notes, net of issuance costs | ||||||||||||||
Capped call transactions related to 2029 Notes | ( | |||||||||||||
| Purchases and retirement of debt | ( | ( | ||||||||||||
Proceeds from NuScale de-SPAC transaction | ||||||||||||||
| Proceeds from sale of NuScale interest | ||||||||||||||
| Dividends paid on CPS | ( | ( | ||||||||||||
Make-whole payment on conversion of CPS | ( | |||||||||||||
| Distributions paid to NCI | ( | ( | ||||||||||||
| Capital contributions by NCI | ||||||||||||||
| Other | ( | ( | ||||||||||||
| Financing cash flow | ||||||||||||||
| Effect of exchange rate changes on cash | ( | ( | ||||||||||||
| Increase (decrease) in cash and cash equivalents | ( | |||||||||||||
| Cash and cash equivalents at beginning of period | ||||||||||||||
| Cash and cash equivalents at end of period | $ | $ | ||||||||||||
| SUPPLEMENTAL INFORMATION: | ||||||||||||||
| Cash paid for interest | $ | $ | ||||||||||||
| Cash paid for income taxes (net of refunds) | ||||||||||||||
The accompanying notes are an integral part of these financial statements.
6
FLUOR CORPORATION
CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY
UNAUDITED
| (in millions, except per share amounts) | Preferred Stock | Common Stock | APIC | AOCI | Retained Earnings | Total Shareholders' Equity | NCI | Total Equity | ||||||||||||||||||||||||
| Shares | Amount | Shares | Amount | |||||||||||||||||||||||||||||
| BALANCE AS OF JUNE 30, 2023 | $ | $ | $ | $ | ( | $ | $ | $ | $ | |||||||||||||||||||||||
Net earnings (loss) | — | — | — | — | — | — | ( | |||||||||||||||||||||||||
| OCI | — | — | — | — | — | ( | — | ( | ( | |||||||||||||||||||||||
Dividends on CPS ($ | — | — | — | — | — | — | ( | ( | — | ( | ||||||||||||||||||||||
Conversion of CPS to common stock (including make-whole payment) | ( | — | — | — | ( | ( | — | ( | ||||||||||||||||||||||||
Capped call transactions related to 2029 Notes | — | — | — | — | ( | — | — | ( | — | ( | ||||||||||||||||||||||
| Distributions to NCI, net of contributions | — | — | — | — | — | — | ( | ( | ||||||||||||||||||||||||
| Stock-based plan activity | — | — | — | — | — | — | — | |||||||||||||||||||||||||
| BALANCE AS OF SEPTEMBER 30, 2023 | $ | $ | $ | ( | $ | $ | $ | $ | ||||||||||||||||||||||||
| (in millions, except per share amounts) | Preferred Stock | Common Stock | APIC | AOCI | Retained Earnings | Total Shareholders' Equity | NCI | Total Equity | ||||||||||||||||||||||||
| Shares | Amount | Shares | Amount | |||||||||||||||||||||||||||||
| BALANCE AS OF DECEMBER 31, 2022 | $ | $ | $ | $ | ( | $ | $ | $ | $ | |||||||||||||||||||||||
| Net earnings (loss) | — | — | — | — | — | — | ( | |||||||||||||||||||||||||
| OCI | — | — | — | — | — | — | ||||||||||||||||||||||||||
Dividends on CPS ($ | — | — | — | — | — | — | ( | ( | — | ( | ||||||||||||||||||||||
Conversion of CPS to common stock (including make-whole payment) | ( | — | — | — | ( | ( | — | ( | ||||||||||||||||||||||||
Capped call transactions related to 2029 Notes | — | — | — | — | ( | — | — | ( | — | ( | ||||||||||||||||||||||
| Distributions to NCI, net of contributions | — | — | — | — | — | — | — | — | ( | ( | ||||||||||||||||||||||
| Other NCI transactions | — | — | — | — | — | — | ||||||||||||||||||||||||||
| Stock-based plan activity | — | — | — | — | — | — | ||||||||||||||||||||||||||
| BALANCE AS OF SEPTEMBER 30, 2023 | $ | $ | $ | ( | $ | $ | $ | $ | ||||||||||||||||||||||||
The accompanying notes are an integral part of these financial statements.
7
FLUOR CORPORATION
CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY (Continued)
UNAUDITED
| (in millions, except per share amounts) | Preferred Stock | Common Stock | APIC | AOCI | Retained Earnings | Total Shareholders' Equity | NCI | Total Equity | ||||||||||||||||||||||||
| Shares | Amount | Shares | Amount | |||||||||||||||||||||||||||||
| BALANCE AS OF JUNE 30, 2022 | $ | $ | $ | $ | ( | $ | $ | $ | $ | |||||||||||||||||||||||
Net earnings (loss) | — | — | — | — | — | — | ( | ( | ||||||||||||||||||||||||
| OCI | — | — | — | — | — | ( | — | ( | — | ( | ||||||||||||||||||||||
Dividends on CPS ($ | — | — | — | — | — | — | ( | ( | — | ( | ||||||||||||||||||||||
| Distributions to NCI, net of capital contributions | — | — | — | — | — | — | — | — | ( | ( | ||||||||||||||||||||||
| NuScale reverse recapitalization | — | — | — | — | — | — | ||||||||||||||||||||||||||
| Other NCI transactions | — | — | — | — | — | — | — | — | ( | ( | ||||||||||||||||||||||
| Stock-based plan activity | — | — | — | — | ( | — | — | ( | — | ( | ||||||||||||||||||||||
| BALANCE AS OF SEPTEMBER 30, 2022 | $ | $ | $ | $ | ( | $ | $ | $ | $ | |||||||||||||||||||||||
| (in millions, except per share amounts) | Preferred Stock | Common Stock | APIC | AOCI | Retained Earnings | Total Shareholders' Equity | NCI | Total Equity | ||||||||||||||||||||||||
| Shares | Amount | Shares | Amount | |||||||||||||||||||||||||||||
| BALANCE AS OF DECEMBER 31, 2021 | $ | $ | $ | $ | ( | $ | $ | $ | $ | |||||||||||||||||||||||
Net earnings (loss) | — | — | — | — | — | — | ( | |||||||||||||||||||||||||
| OCI | — | — | — | — | — | ( | — | ( | — | ( | ||||||||||||||||||||||
Dividends on CPS ($ | — | — | — | — | — | — | ( | ( | — | ( | ||||||||||||||||||||||
| Distributions to NCI, net of capital contributions | — | — | — | — | — | — | — | — | ( | ( | ||||||||||||||||||||||
| NuScale reverse recapitalization | — | — | — | — | — | — | ||||||||||||||||||||||||||
| Other NCI transactions | — | — | — | — | — | — | — | |||||||||||||||||||||||||
| Stock-based plan activity | — | — | — | — | — | — | ||||||||||||||||||||||||||
| BALANCE AS OF SEPTEMBER 30, 2022 | $ | $ | $ | $ | ( | $ | $ | $ | $ | |||||||||||||||||||||||
The accompanying notes are an integral part of these financial statements.
8
1. Principles of Consolidation
These financial statements do not include footnotes and certain financial information presented annually under GAAP, and therefore, should be read in conjunction with our 2022 10-K. Accounting measurements at interim dates inherently involve greater reliance on estimates than at year-end. Although such estimates are based on management’s most recent assessment of the underlying facts and circumstances utilizing the most current information available, our reported results of operations may not necessarily be indicative of results that we expect for the full year.
The financial statements included herein are unaudited. We believe they contain all adjustments of a normal recurring nature which are necessary to present fairly our financial position and our operating results as of and for the periods presented. All significant intercompany transactions of consolidated subsidiaries are eliminated. Certain amounts in tables may not total or agree back to the financial statements due to immaterial rounding differences. Management has evaluated all material events occurring subsequent to September 30, 2023 through the filing date of this Q3 2023 10-Q.
Quarters are typically 13 weeks in length but, due to our December 31 year-end, the number of weeks in a reporting period may vary slightly during the year and for comparable prior year periods. We report our quarterly results of operations based on periods ending on the Sunday nearest March 31, June 30 and September 30, allowing for 13-week interim reporting periods. For clarity of presentation, all periods are labeled as if the periods ended on March 31, June 30 and September 30.
2. Recent Accounting Pronouncements
We did not implement any new accounting pronouncements during the 2023 Period. However, we are evaluating the impact of the future disclosures that may arise under recent SEC and other promulgators' recently finalized rules and outstanding proposals, some of which will require new disclosures beginning with our next 10-K filing.
In the 2023 Period, the SEC approved listing standards proposed by the New York Stock Exchange that require listed companies to recover or “clawback” incentive-based compensation erroneously received by current and former executive officers in the event of a restatement to previously issued financial information. We are required to amend our clawback policy by December 2023, but do not expect the adoption will have any impact on our financial statements.
In the 2023 Quarter, the Financial Accounting Standards Board issued ASU 2023-05, which requires certain joint ventures to apply a new basis of accounting upon formation by recognizing and initially measuring most of their assets and liabilities at fair value. The guidance does not apply to joint ventures that may be proportionately consolidated and those
that are collaborative arrangements. ASU 2023-05 is effective for joint venture with a formation date on or after January 1, 2025. We do not expect this ASU will have a material impact on our financial statements.
9
3. Earnings Per Share
Potentially dilutive securities include CPS, convertible debt, stock options, RSUs and performance-based award units. Diluted EPS reflects the assumed exercise or conversion of all dilutive securities using the if-converted and treasury stock methods. In computing diluted EPS, only securities that are actually dilutive are included.
| 3ME September 30, | 9ME September 30, | |||||||||||||||||||||||||
| (in millions, except per share amounts) | 2023 | 2022 | 2023 | 2022 | ||||||||||||||||||||||
Net earnings attributable to Fluor | $ | $ | $ | $ | ||||||||||||||||||||||
Less: Dividends on CPS | ||||||||||||||||||||||||||
Less: Make-whole payment on conversion of CPS | ||||||||||||||||||||||||||
Net earnings available to Fluor common stockholders | ||||||||||||||||||||||||||
| Weighted average common shares outstanding | ||||||||||||||||||||||||||
| Diluted effect: | ||||||||||||||||||||||||||
| CPS | ||||||||||||||||||||||||||
| Stock options, RSUs and performance-based award units | ||||||||||||||||||||||||||
Convertible debt (1) | ||||||||||||||||||||||||||
| Weighted average diluted shares outstanding | ||||||||||||||||||||||||||
| Basic EPS available to Fluor common stockholders | $ | $ | $ | $ | ||||||||||||||||||||||
| Diluted EPS available to Fluor common stockholders | $ | $ | $ | $ | ||||||||||||||||||||||
| Anti-dilutive securities not included in shares outstanding: | ||||||||||||||||||||||||||
| CPS | ||||||||||||||||||||||||||
| Stock options, RSUs and performance-based award units | ||||||||||||||||||||||||||
Stock delivered under capped call options (2) | ||||||||||||||||||||||||||
(1) Holders of our 2029 Notes may convert their notes at a conversion price of $45.37 per share when the stock price exceeds $58.98 for 20 of the last 30 days preceding quarter end. Upon conversion, we will repay the principal amount of the notes in cash and may elect to convey the conversion premium in cash, shares of our common stock or a combination of both. The conversion feature of our 2029 Notes will have a dilutive impact on EPS when the average market price of our common stock exceeds the conversion price of $45.37 per share for the quarter. During the 2023 Quarter, the weighted average price per share of our common stock was less than the minimum conversion price.
(2) Diluted shares outstanding does not include the impact of the capped call options we entered into concurrently with the issuance of the 2029 Notes, as the effect is always anti-dilutive. If shares are delivered to us under the capped calls, those shares will offset the dilutive effect of the shares that we would issue upon conversion of the 2029 Notes.
10
4. Operating Information by Segment and Geographic Area
We have decided to retain Stork's North American operations, which largely consists of our operations and maintenance business owned by Fluor prior to our acquisition of Stork. Beginning in 2023, this business line, which was previously a part of the "Other" segment, was renamed Plant & Facility Services, and is included in our Urban Solutions segment for all periods presented.
| 3ME September 30, | 9ME September 30, | |||||||||||||||||||||||||
| (in millions) | 2023 | 2022 | 2023 | 2022 | ||||||||||||||||||||||
| Revenue | ||||||||||||||||||||||||||
| Energy Solutions | $ | $ | $ | $ | ||||||||||||||||||||||
| Urban Solutions | ||||||||||||||||||||||||||
| Mission Solutions | ||||||||||||||||||||||||||
| Other | ||||||||||||||||||||||||||
| Total revenue | $ | $ | $ | $ | ||||||||||||||||||||||
| Segment profit (loss) | ||||||||||||||||||||||||||
| Energy Solutions | $ | $ | $ | $ | ||||||||||||||||||||||
| Urban Solutions | ( | ( | ||||||||||||||||||||||||
| Mission Solutions | ||||||||||||||||||||||||||
| Other | ( | ( | ( | ( | ||||||||||||||||||||||
| Total segment profit | $ | $ | $ | $ | ||||||||||||||||||||||
| G&A | ( | ( | ( | ( | ||||||||||||||||||||||
| Impairment | ||||||||||||||||||||||||||
| Foreign currency gain (loss) | ( | |||||||||||||||||||||||||
| Interest income (expense), net | ||||||||||||||||||||||||||
| Earnings (loss) attributable to NCI | ( | ( | ( | ( | ||||||||||||||||||||||
| Earnings before taxes | $ | $ | $ | $ | ||||||||||||||||||||||
| Intercompany revenue for our professional staffing business, excluded from revenue above | $ | $ | $ | $ | ||||||||||||||||||||||
Energy Solutions. Segment profit for the 2023 Quarter and 2023 Period significantly improved. Both periods benefitted from the initial recognition of cost recovery entitlements on several fixed price projects. Segment profit for the 2023 Quarter also included a gain of $24 million on embedded foreign currency derivatives compared to a loss of $5 million in the 2022 Quarter. Segment profit for the 2023 Period included the ramp up of execution activities on our refinery projects in Mexico as well as the effects of favorable foreign currency remeasurement. Despite the overall increase in segment profit, the 2023 Period included charges of $58 million (or $0.34 per share) for cost growth on a large upstream legacy project.
Urban Solutions. Segment profit for the 2023 Quarter and 2023 Period significantly improved. Segment profit in the 2023 Quarter includes an incentive fee award on a large mining project that is nearing completion as well as a favorable arbitration outcome on a separate mining project whereas segment profit in the 2022 Quarter included charges related to cost growth and schedule delays on three legacy infrastructure projects. Segment profit in the 2023 Period included a $59 million (or $0.34 per share) charge for rework associated with subcontractor design errors, related schedule impacts and system integration testing timelines on the LAX Automated People Mover project. Segment profit for the 2022 Period included an $86 million (or $0.50 per share) charge for additional rework and schedule delays on a highway project, a $54 million (or $0.23 per share) charge for cost growth and delay mitigation costs on an international bridge project and a $35 million (or $$0.20 per share) charge for subcontractor cost escalation and productivity estimates on the LAX Automated People Mover project.
11
Mission Solutions. Segment profit improved in the 2023 Quarter driven by execution for FEMA hurricane support. Additionally, the 2022 Quarter included an incremental charge for cost growth on a weapons facility project. Segment profit in the 2023 Period included a $30 million (or $0.17 per share) charge for cost growth resulting from additional schedule delays on the weapons facility project. We are conducting our due diligence to recover cost growth that has resulted from directed and constructive changes from the client on the project.
Other. Segment profit (loss) for NuScale, Stork and AMECO follows:
3ME September 30, | 9ME September 30, | ||||||||||||||||||||||
| (in millions) | 2023 | 2022 | 2023 | 2022 | |||||||||||||||||||
NuScale(1) | $ | ( | $ | ( | $ | ( | $ | ( | |||||||||||||||
| Stork | |||||||||||||||||||||||
| AMECO | ( | ||||||||||||||||||||||
| Segment profit (loss) | $ | ( | $ | ( | $ | ( | $ | ( | |||||||||||||||
(1) As of September 30, 2023, we had an approximate 55 % ownership in NuScale.
In March 2023, we sold our AMECO South America business, which included operations in Chile and Peru. This transaction marked the completion of the AMECO divestiture for total proceeds of $144 million, including $17 million during the 2023 Period. Previous AMECO divestitures included assets in Africa, the Caribbean, Mexico and North America. Upon the sale of AMECO South America in the 2023 Period, we recognized a $60 million negative earnings impact, including $35 million associated with foreign currency translation.
Total assets by segment are as follows:
| (in millions) | September 30, 2023 | December 31, 2022 | ||||||||||||
| Energy Solutions | $ | $ | ||||||||||||
| Urban Solutions | ||||||||||||||
| Mission Solutions | ||||||||||||||
| Other | ||||||||||||||
| Corporate | ||||||||||||||
| Total assets | $ | $ | ||||||||||||
Revenue by project location follows:
| 3ME September 30, | 9ME September 30, | |||||||||||||||||||||||||
| (in millions) | 2023 | 2022 | 2023 | 2022 | ||||||||||||||||||||||
| North America | $ | $ | $ | $ | ||||||||||||||||||||||
| Asia Pacific (includes Australia) | ||||||||||||||||||||||||||
| Europe | ||||||||||||||||||||||||||
| Central and South America | ||||||||||||||||||||||||||
| Middle East and Africa | ||||||||||||||||||||||||||
| Total revenue | $ | $ | $ | $ | ||||||||||||||||||||||
5. Impairment
12
6. Income Taxes
The effective tax rate on earnings was 30.4 % for the 2023 Quarter and 59.1 % for the 2023 Period compared to 939.2 % for the 2022 Quarter and 46.0 % for the 2022 Period. A reconciliation of U.S. statutory federal income tax expense to income tax expense follows:
| 3ME September 30 | 9ME September 30 | ||||||||||||||||||||||
| (In millions) | 2023 | 2022 | 2023 | 2022 | |||||||||||||||||||
| U.S statutory federal income tax expense | $ | $ | $ | $ | |||||||||||||||||||
| Increase (decrease) in taxes resulting from: | |||||||||||||||||||||||
| State and local income taxes, net of federal income tax effects | |||||||||||||||||||||||
| Valuation allowance, net | |||||||||||||||||||||||
| Foreign tax impacts | ( | ( | |||||||||||||||||||||
| Noncontrolling interest | |||||||||||||||||||||||
| Sale of AMECO South America | ( | ||||||||||||||||||||||
| Other adjustments | |||||||||||||||||||||||
| Total income tax expense | $ | $ | $ | $ | |||||||||||||||||||
7. Partnerships and Joint Ventures
Many of our partnership and joint venture agreements provide for capital calls to fund operations, as necessary. Investments in a loss position of $342 million and $312 million were included in other accrued liabilities as of September 30, 2023 and December 31, 2022, respectively, and consisted primarily of provision for anticipated losses on two legacy infrastructure projects. Accounts receivable related to work performed for unconsolidated partnerships and joint ventures included in “Accounts receivable, net” was $173 million and $185 million as of September 30, 2023 and December 31, 2022, respectively.
Variable Interest Entities
The aggregate carrying value of unconsolidated VIEs (classified under both "Investments” and “Other accrued liabilities”) was a net asset of $14 million and $46 million as of September 30, 2023 and December 31, 2022, respectively. Some of our VIEs have debt; however, such debt is typically non-recourse in nature. Our maximum exposure to loss as a result of our investments in unconsolidated VIEs is typically limited to the aggregate of the carrying value of the investment and future funding necessary to satisfy the contractual obligations of the VIE. Future funding commitments as of September 30, 2023 for the unconsolidated VIEs were $57 million.
We are required to consolidate certain VIEs. Assets and liabilities associated with the operations of our consolidated VIEs are presented on the balance sheet. The assets of a VIE are restricted for use only for the particular VIE and are not available for our general operations. We have agreements with certain VIEs to provide financial or performance assurances to clients, as discussed elsewhere.
8. Guarantees
13
9. Commitments and Contingencies
We and certain of our subsidiaries are subject to litigation, claims and other commitments and contingencies, including matters arising in the ordinary course of business, of which the asserted value may be significant. We record accruals in the financial statements for contingencies when we determine that an unfavorable outcome is probable and the amount of the loss can be reasonably estimated. While there is at least a reasonable possibility that a loss may be incurred in any of the matters identified below, including a loss in excess of amounts accrued, management is unable to estimate the possible loss or range of loss or has determined such amounts to be immaterial. At present, except as set forth below, we do not expect that the ultimate resolution of any open matters will have a material adverse effect on our financial position or results of operations. However, legal proceedings and regulatory and governmental matters are subject to inherent uncertainties, and unfavorable rulings or other events could occur. Unfavorable outcomes could involve substantial monetary damages, fines, penalties and other expenditures. An unfavorable outcome might result in a material adverse impact on our business, results of operations or financial position. We might also enter into an agreement to settle one or more such matters if we determine such settlement is in the best interests of our stakeholders, and any such settlement could include substantial payments.
The following disclosures for commitments and contingencies have been updated since the matter was presented in the 2022 10-K.
Fluor Australia Ltd., our wholly-owned subsidiary (“Fluor Australia”), completed a cost reimbursable engineering, procurement and construction management services project for Santos Ltd. (“Santos”) involving a large network of natural gas gathering and processing facilities in Queensland, Australia. On December 13, 2016, Santos filed an action in Queensland Supreme Court (the “Court”) against Fluor Australia, asserting various causes of action and seeking damages and/or a refund of contract proceeds paid of AUD $1.47 billion. Santos has joined Fluor to the matter on the basis of a parent company guarantee issued for the project. In March 2023, a panel of three referees appointed by the Court (the "Panel”) issued a draft, non-binding report setting forth recommendations to the Court regarding liability and damages in the lawsuit. After consideration of further submissions by the parties, the Panel finalized its report on July 14, 2023. The Panel’s report has no legal effect unless it is adopted by the Court through an adoption hearing, and the Court can accept or reject, in whole or in part, the Panel’s recommendations. In the final report, the Panel recommended judgment for Fluor on one of Santos’s damages claims that Santos contends has an approximate value of AUD $700 million, and recommended judgment for Santos on other claims that the Panel valued at AUD $790 million. While the project contract contains a liability cap of approximately AUD $236 million, the Panel found that the liability cap did not apply to Santos’s claims. Fluor has made an application to have the Court set aside the reference to the Panel and the Panel’s recommendations on several procedural and substantive grounds, including in relation to apparent bias of the referees, a failure to comply with the order which established the reference to the Panel and a lack of procedural fairness. In July 2023, the Court held oral argument on that application. We do not expect a decision until after the Court holds an adoption hearing, which is scheduled for February 2024. At any adoption hearing, Fluor will contend that the Court should not adopt the Panel’s recommendation based on numerous grounds, including the Panel’s failure to apply the project’s liability cap.
Fluor Limited, our wholly-owned subsidiary (“Fluor Limited”), and Fluor Arabia Limited, a partially-owned subsidiary (“Fluor Arabia”), completed cost reimbursable engineering, procurement and construction management services for Sadara Chemical Company (“Sadara”) involving a large petrochemical facility in Jubail, Kingdom of Saudi Arabia. On August 23, 2019, Fluor Limited and Fluor Arabia Limited commenced arbitration proceedings against Sadara after it refused to pay invoices totaling approximately $100 million due under the contracts. As part of the arbitration proceedings, Sadara asserted various counterclaims for damages and/or a refund of contract proceeds paid totaling $574 million against Fluor Limited and Fluor Arabia Limited. In August 2023, the arbitration panel issued an award on the majority of our invoice claims and on a small portion of Sadara's claims. Based on our current assessment of the award, we recorded a charge of $14 million in the 2023 Quarter to reflect the expected net settlement with Sadara for all non-interest claims. Additionally, after October 2023, we expect to collect and recognize as income $3 million associated with interest arising from the arbitration award. Both Fluor and Sadara have requested clarifications regarding the arbitration award, which also may result in adjustments in future quarters.
Since September 2018, eleven separate purported shareholders' derivative actions were filed against current and former members of the Board of Directors, as well as certain of Fluor’s current and former executives. Fluor was named as a nominal defendant in the actions. These derivative actions purported to assert claims on behalf of Fluor and made substantially the same factual allegations as the securities class action matter which was resolved in 2022, as previously disclosed in our 2022 10-K, and sought various forms of monetary and injunctive relief. These actions were pending in Texas state court (District
14
Court for Dallas County), the U.S. District Court for the District of Delaware, the U.S. District Court for the Northern District of Texas, and the Court of Chancery of the State of Delaware. In April 2023, the parties reached an agreement for a global settlement of these matters. The settlement received final court approval in September 2023. All matters have now been dismissed.
In February 2020, we announced that the SEC was conducting an investigation and requested documents and information related to projects for which we recorded charges in the second quarter of 2019. In April 2020 and January 2022, Fluor received subpoenas from the U.S. DOJ seeking documents and information related to the second quarter 2019 charges; certain of the projects associated with those charges; and certain project accounting, financial reporting and governance matters. In May 2023, the DOJ advised that it had closed its investigation and does not intend to bring charges. In September 2023, we entered into a settlement agreement with the SEC resolving the investigation and agreed to pay a civil penalty of $15 million. We had previously established reserves sufficient to fund the settlement. Therefore, the settlement did not have a material impact on our results during the 2023 Quarter.
Various wholly-owned subsidiaries of Fluor, in conjunction with a partner, TECHINT, (“Fluor/TECHINT”) performed engineering, procurement and construction management services on a cost reimbursable basis for Barrick Gold Corporation involving a gold mine and ore processing facility on a site straddling the border between Argentina and Chile. In 2013 Barrick terminated the Fluor/TECHINT agreements for convenience and not due to the performance of Fluor/TECHINT. On August 12, 2016, Barrick filed a notice of arbitration against Fluor/TECHINT, demanding damages and/or a refund of contract proceeds paid of not less than $250 million under various claims relating to Fluor/TECHINT’s alleged performance. Proceedings were suspended while the parties explored a possible settlement. In August 2019, Barrick drew down $36 million of letters of credit from Fluor/TECHINT ($24 million from Fluor and $12 million from TECHINT). Thereafter, Barrick proceeded to reactivate the arbitration. Barrick and Fluor/TECHINT exchanged detailed statements of claim and counterclaim pursuant to which Barrick's claim against Fluor/TECHINT totaled $364 million net of amounts acknowledged to be due to Fluor/TECHINT. In September 2023, the arbitration panel issued an award generally in favor of Fluor/TECHINT. In October 2023, Fluor/TECHINT and Barrick entered into an agreement to effect the arbitration award and release all claims among the parties. We recognized a gain of $12 million in the 2023 Quarter associated with the non-interest component and expect to recognize an additional $11 million on the interest component in the fourth quarter of 2023.
15
10. Contract Assets and Liabilities
The following summarizes information about our contract assets and liabilities:
| (in millions) | September 30, 2023 | December 31, 2022 | ||||||
| Information about contract assets: | ||||||||
| Contract assets | ||||||||
| Unbilled receivables - reimbursable contracts | $ | $ | ||||||
| Contract work in progress - lump-sum contracts | ||||||||
| Contract assets | $ | $ | ||||||
| Advance billings deducted from contract assets | $ | $ | ||||||
| 9ME September 30, | ||||||||
| (in millions) | 2023 | 2022 | ||||||
| Information about contract liabilities: | ||||||||
| Revenue recognized that was included in contract liabilities as of January 1 | $ | $ | ||||||
11. Remaining Unsatisfied Performance Obligations
We estimate that our RUPO will be satisfied over the following periods:
| (in millions) | September 30, 2023 | ||||
| Within 1 year | $ | ||||
| 1 to 2 years | |||||
| Thereafter | |||||
| Total RUPO | $ | ||||
16
12. Debt and Letters of Credit
| (in millions) | September 30, 2023 | December 31, 2022 | |||||||||
| Borrowings under credit facility | $ | $ | |||||||||
| Current: | |||||||||||
| 2023 Notes | $ | $ | |||||||||
| Other borrowings | |||||||||||
| Total current | $ | $ | |||||||||
| Long-term: | |||||||||||
| Senior Notes | |||||||||||
| 2024 Notes | |||||||||||
Unamortized discount and deferred financing costs | ( | ||||||||||
| 2028 Notes | |||||||||||
Unamortized discount and deferred financing costs | ( | ( | |||||||||
| 2029 Notes | |||||||||||
| Unamortized deferred financing costs | ( | ||||||||||
| Other long-term borrowings | |||||||||||
| Total long-term | $ | $ | |||||||||
Credit Facility
As of September 30, 2023, letters of credit totaling $422 million were outstanding under our $1.8 billion credit facility, which matures in February 2026 and was amended in August 2023 to permit the issuance of the 2029 Notes. This credit facility contains customary financial covenants, including a debt-to-capitalization ratio that cannot exceed 0.60 to 1.00 , a limitation on the aggregate amount of debt of the greater of $750 million or €750 million for our subsidiaries, and a minimum liquidity threshold of $1.5 billion, all as defined in the amended credit facility, which may be reduced to $1.0 billion upon the repayment of debt. The credit facility also contains provisions that will require us to provide collateral to secure the facility should we be downgraded to BB by S&P and Ba2 by Moody's, such collateral consisting broadly of our U.S. assets. Borrowings under the facility, which may be denominated in USD, EUR, GBP or CAD, bear interest at a base rate, plus an applicable borrowing margin. As of September 30, 2023, we had not made any borrowings under our credit facility and maintained a borrowing capacity of $797 million.
Uncommitted Lines of Credit
As of September 30, 2023, letters of credit totaling $920 million were outstanding under uncommitted lines of credit.
Issuance of 2029 Notes
In August 2023, we issued $575 million of 1.125 % Convertible Senior Notes (the “2029 Notes”) due August 15, 2029 and received net proceeds of $560 million. Interest on the 2029 Notes is payable semi-annually on February 15 and August 15, beginning on February 15, 2024. The conversion rate for the 2029 Notes is 22.0420 shares of common stock per $1,000 principal amount of notes, which is equivalent to an initial conversion price of $45.37 per share. Holders may convert their 2029 Notes any time before May 2029 under the following conditions:
•if the last reported price of our common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter is greater than or equal to $58.98 on each applicable trading day;
•during the five -business day period after any five -consecutive trading day period in which the trading price of the 2029 Notes was less than 98 % of the product of the last reported stock price and the conversion rate;
•if we call any or all of the 2029 Notes for redemption; or
17
•upon the occurrence of specified events as described in the applicable indenture.
In addition, holders may convert their 2029 Notes any time beginning on May 15, 2029 and prior to maturity without regard to the foregoing circumstances. Upon any conversion, we will repay the principal amount of the notes in cash and may elect to convey the conversion premium in any combination of cash and shares of our common stock. Certain events could cause the conversion rate to increase, including a make-whole fundamental change or redemption, but in no event will the conversion rate for a single note exceed 29.2056 shares of our common stock, other than for customary adjustments described in the applicable indenture.
After August 2026, we may elect to redeem up to all of the outstanding 2029 Notes if our common stock has a prevailing per share closing price in excess of $58.98 . In such election, all principal would be settled in cash and could result in a make-whole premium if the holders also elect to convert. We may elect to pay any make-whole premium in any combination of cash and shares of our common stock.
Capped Call Transactions
In connection with the 2029 Notes offering, we entered into capped call transactions with certain banks. The strike price of the capped call options corresponds to the conversion price of the 2029 Notes of $45.37 per share. The capped call options are expected to offset potential dilution to our common stock upon conversion of any 2029 Notes and/or offset any cash payments we are required to make for any conversion premium if our stock price is greater than $45.37 . The upper limit of the capped calls is $68.48 per share. If our stock price exceeds $68.48 , there would be unmitigated dilution and/or no offset of any cash payments attributable to the amount by which our stock exceeds the cap price. We will not be required to make any cash payments to option counterparties upon the exercise of capped call options, but we will be entitled to receive from them shares of our common stock or an amount of cash based on the amount by which the market price of our common stock exceeds the strike price of the capped calls. The capped call transactions are not part of the terms of the 2029 Notes and are accounted for as separate transactions. As the capped call options are indexed to our own stock, they are recorded in shareholders’ equity and are not accounted for as derivatives. The cost of the capped call transactions was $73 million which was recorded as a reduction to APIC, and will not be subject to periodic remeasurement.
Redemption of 2024 and 2023 Notes
In August 2023, we completed a tender offer in which we repurchased $115 million of outstanding 2024 Notes, excluding accrued interest, for consideration of $975.03 per $1,000 principal amount of the notes. The earnings effect of the tender offer was immaterial.
In January 2023, we redeemed the remaining €129 million of outstanding 2023 Notes for $140 million with no earnings impact.
13. Convertible Preferred Stock
In September 2023, we exercised our mandatory conversion rights on our CPS in which all of the outstanding shares of CPS converted to 44.9585 shares of our common stock, plus a cash payment of $45.23 per CPS for a make-whole premium. The total make-whole premium amounted to $27 million.
Third quarter CPS dividends of $10 million were paid in August 2023. Upon conversion, all dividends on the CPS have ceased. We have no obligation for accumulated but unpaid dividends since the last record date.
18
14. Fair Value Measurements
The following table delineates assets and liabilities that are measured at fair value on a recurring basis:
| September 30, 2023 | December 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Fair Value Hierarchy | Fair Value Hierarchy | |||||||||||||||||||||||||||||||||||||||||||||||||
| (in millions) | Total | Level 1 | Level 2 | Level 3 | Total | Level 1 | Level 2 | Level 3 | ||||||||||||||||||||||||||||||||||||||||||
| Assets: | ||||||||||||||||||||||||||||||||||||||||||||||||||
Marketable securities, noncurrent(1) | $ | $ | — | $ | $ | — | $ | — | $ | — | $ | — | $ | — | ||||||||||||||||||||||||||||||||||||
Deferred compensation trusts(2) | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||
Derivative assets(3) | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Foreign currency | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||
| Commodity | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||
| Liabilities: | ||||||||||||||||||||||||||||||||||||||||||||||||||
SMR warrants (4) | $ | $ | $ | $ | — | $ | $ | $ | $ | — | ||||||||||||||||||||||||||||||||||||||||
Derivative liabilities(3) | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Foreign currency | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||
| Commodity | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||
_________________________________________________________
(1) Consists of investments in U.S. Treasury notes with maturities greater than one year that are valued based on pricing models, which are determined from a compilation of primarily observable market information, broker quotes in non-active markets or similar assets.
(2) Consists of registered money market funds and an equity index fund. These investments, which are trading securities, represent the net asset value at the close of business of the period based on the last trade or official close of an active market or exchange.
(3) Foreign currency and commodity derivatives are estimated using pricing models with market-based inputs, which take into account the present value of estimated future cash flows.
(4) The SMR warrant liabilities are comprised of public and private placement warrants redeemable by SMR under certain conditions, both measured using the price of the public warrants. The private placement warrants are not publicly traded and have been classified as Level 2 measurements while the public warrants are classified as Level 1.
19
We have measured assets and liabilities held for sale at fair value on a nonrecurring basis. The following summarizes information about financial instruments that are not required to be measured at fair value:
| September 30, 2023 | December 31, 2022 | ||||||||||||||||||||||||||||
| (in millions) | Fair Value Hierarchy | Carrying Value | Fair Value | Carrying Value | Fair Value | ||||||||||||||||||||||||
| Assets: | |||||||||||||||||||||||||||||
Cash(1) | Level 1 | $ | $ | $ | $ | ||||||||||||||||||||||||
Cash equivalents(2) | Level 2 | ||||||||||||||||||||||||||||
Marketable securities, current(2) | Level 2 | ||||||||||||||||||||||||||||
Notes receivable, including noncurrent portion(3) | Level 3 | ||||||||||||||||||||||||||||
| Liabilities: | |||||||||||||||||||||||||||||
2023 Senior Notes(4) | Level 2 | $ | $ | $ | $ | ||||||||||||||||||||||||
2024 Senior Notes(4) | Level 2 | ||||||||||||||||||||||||||||
2028 Senior Notes(4) | Level 2 | ||||||||||||||||||||||||||||
2029 Senior Notes(4) | Level 2 | ||||||||||||||||||||||||||||
Other borrowings, including noncurrent portion(5) | Level 2 | ||||||||||||||||||||||||||||
_________________________________________________________
(1) Cash consists of bank deposits. Carrying amounts approximate fair value.
(2) Cash equivalents and marketable securities, current primarily consists of time deposits. Carrying amounts approximate fair value because of the short-term maturity of these instruments. Amortized cost is not materially different from the fair value.
(3) Notes receivable are carried at net realizable value which approximates fair value. Factors considered in determining the fair value include the credit worthiness of the borrower, current interest rates, the term of the note and any collateral pledged as security. Notes receivable are periodically assessed for impairment.
(4) The fair value of the Senior Notes was estimated based on the quoted market prices and Level 2 inputs.
(5) Other borrowings represent bank loans and other financing arrangements which mature within one year. The carrying amount of borrowings under these arrangements approximates fair value because of the short-term maturity.
15. Stock-Based Compensation
Equity Awards
Our executive and director stock-based compensation plans are described more fully in the 2022 10-K. In the 2023 and 2022 Periods, RSUs totaling 432,654 and 415,356 , respectively, were granted to executives and directors at a weighted-average grant date fair value of $34.88 and $22.36 per share, respectively, and generally vest over three years
Stock options for the purchase of 178,434 and 250,656 shares at a weighted-average exercise price of $35.76 and $21.90 per share were awarded to executives during the 2023 and 2022 Periods, respectively. The options granted in 2023 and 2022 generally vest over three years and expire ten years after the grant date.
Performance-based award units totaling 274,755 were awarded to certain senior executives and all of Section 16 officers during the 2023 Period and performance-based award units totaling 426,957 were awarded to Section 16 officers during the 2022 Period. These awards generally cliff vest after three years and contain annual performance conditions for each of the three years of the vesting period. Under GAAP, performance-based elements of such awards are not deemed granted until the performance targets have been established. The performance targets for each year are generally established in the first quarter. For awards granted under the 2023 performance plan, 80 % of the award is earned based on achievement of earnings
20
before taxes targets over three one-year periods and 20 % of the award is earned based on our three-year cumulative TSR relative to companies in the S&P 500 on the date of the award. For the majority of awards, generally only one-third of the units awarded in any given year are deemed to be granted each year of the three-year vesting periods. During 2023, the following units were granted based upon the establishment of performance targets:
| Performance-based Award Units Granted in 2023 | Weighted Average Grant Date Fair Value Per Share | |||||||
| 2023 Performance Award Plan | $ | |||||||
| 2022 Performance Award Plan | $ | |||||||
| 2021 Performance Award Plan | $ | |||||||
For awards granted under the 2023, 2022 and 2021 performance award plans, the number of units are adjusted during the vesting period to reflect actual and forecasted achievement of the specified performance targets, as defined in the award agreements.
Liability Awards
SGI awards and performance-based awards for other executives vest and become payable at a rate of one-third of the total award each year.
| Location in Statement of Operations | 3ME September 30, | 9ME September 30, | ||||||||||||||||||||||||
| (in millions) | 2023 | 2022 | 2023 | 2022 | ||||||||||||||||||||||
| SGI awards | G&A | $ | $ | $ | $ | |||||||||||||||||||||
| Performance-based awards for other executives | G&A | |||||||||||||||||||||||||
| Liabilities (in millions) | Location on Balance Sheet | September 30, 2023 | December 31, 2022 | |||||||||||
| SGI awards | Accrued salaries, wages and benefits and other noncurrent liabilities | $ | $ | |||||||||||
| Performance-based awards for other executives | Accrued salaries, wages and benefits and other noncurrent liabilities | |||||||||||||
16. Other Comprehensive Income (Loss)
The components of OCI follow:
| 3ME September 30, 2023 | 3ME September 30, 2022 | |||||||||||||||||||||||||||||||||||||
| (in millions) | Before-Tax Amount | Tax Benefit (Expense) | Net-of-Tax Amount | Before-Tax Amount | Tax Benefit (Expense) | Net-of-Tax Amount | ||||||||||||||||||||||||||||||||
| OCI: | ||||||||||||||||||||||||||||||||||||||
| Foreign currency translation adjustments | $ | ( | $ | $ | ( | $ | ( | $ | $ | ( | ||||||||||||||||||||||||||||
| Ownership share of equity method investees’ OCI | ( | |||||||||||||||||||||||||||||||||||||
| Other | ( | ( | ( | ( | ||||||||||||||||||||||||||||||||||
| Total OCI | ( | ( | ( | ( | ( | |||||||||||||||||||||||||||||||||
| Less: OCI attributable to NCI | ||||||||||||||||||||||||||||||||||||||
| OCI attributable to Fluor | $ | ( | $ | $ | ( | $ | ( | $ | ( | $ | ( | |||||||||||||||||||||||||||
21
| 9ME September 30, 2023 | 9ME September 30, 2022 | |||||||||||||||||||||||||||||||||||||
| (in millions) | Before-Tax Amount | Tax Benefit (Expense) | Net-of-Tax Amount | Before-Tax Amount | Tax Benefit (Expense) | Net-of-Tax Amount | ||||||||||||||||||||||||||||||||
| OCI: | ||||||||||||||||||||||||||||||||||||||
| Foreign currency translation adjustments | $ | $ | $ | $ | ( | $ | $ | ( | ||||||||||||||||||||||||||||||
| Ownership share of equity method investees’ OCI | ( | ( | ( | |||||||||||||||||||||||||||||||||||
| Other | ( | ( | ||||||||||||||||||||||||||||||||||||
| Total OCI | ( | ( | ( | |||||||||||||||||||||||||||||||||||
| Less: OCI attributable to NCI | ||||||||||||||||||||||||||||||||||||||
| OCI attributable to Fluor | $ | $ | $ | $ | ( | $ | ( | $ | ( | |||||||||||||||||||||||||||||
The changes in AOCI balances follow:
| (in millions) | Foreign Currency Translation | Ownership Share of Equity Method Investees’ OCI | Other | AOCI, Net | |||||||||||||||||||
| Attributable to Fluor: | |||||||||||||||||||||||
| Balance as of June 30, 2023 | $ | ( | $ | ( | $ | ( | $ | ( | |||||||||||||||
| OCI before reclassifications | ( | ( | |||||||||||||||||||||
| Amounts reclassified from AOCI | ( | ( | |||||||||||||||||||||
| Net OCI | ( | ( | ( | ||||||||||||||||||||
| Balance as of September 30, 2023 | $ | ( | $ | ( | $ | ( | $ | ( | |||||||||||||||
| 0 | |||||||||||||||||||||||
| Attributable to NCI: | 0 | ||||||||||||||||||||||
| Balance as of June 30, 2023 | $ | ( | $ | $ | $ | ( | |||||||||||||||||
| OCI before reclassifications | |||||||||||||||||||||||
| Amounts reclassified from AOCI | |||||||||||||||||||||||
| Net OCI | |||||||||||||||||||||||
| Balance as of September 30, 2023 | $ | $ | $ | $ | |||||||||||||||||||
22
| (in millions) | Foreign Currency Translation | Ownership Share of Equity Method Investees’ OCI | Other | AOCI, Net | |||||||||||||||||||
| Attributable to Fluor: | |||||||||||||||||||||||
| Balance as of December 31, 2022 | $ | ( | $ | ( | $ | ( | $ | ( | |||||||||||||||
| OCI before reclassifications | ( | ||||||||||||||||||||||
| Amounts reclassified from AOCI | |||||||||||||||||||||||
| Net OCI | ( | ||||||||||||||||||||||
| Balance as of September 30, 2023 | $ | ( | $ | ( | $ | ( | $ | ( | |||||||||||||||
| 0 | |||||||||||||||||||||||
| Attributable to NCI: | 0 | ||||||||||||||||||||||
| Balance as of December 31, 2022 | $ | ( | $ | $ | $ | ( | |||||||||||||||||
| OCI before reclassifications | |||||||||||||||||||||||
| Amounts reclassified from AOCI | |||||||||||||||||||||||
| Net OCI | |||||||||||||||||||||||
| Balance as of September 30, 2023 | $ | $ | $ | $ | |||||||||||||||||||
| (in millions) | Foreign Currency Translation | Ownership Share of Equity Method Investees’ OCI | Other | AOCI, Net | |||||||||||||||||||
| Attributable to Fluor: | |||||||||||||||||||||||
| Balance as of June 30, 2022 | $ | ( | $ | ( | $ | ( | $ | ( | |||||||||||||||
| OCI before reclassifications | ( | ( | ( | ||||||||||||||||||||
| Amounts reclassified from AOCI | |||||||||||||||||||||||
| Net OCI | ( | ( | ( | ||||||||||||||||||||
| Balance as of September 30, 2022 | $ | ( | $ | ( | $ | ( | $ | ( | |||||||||||||||
| 0 | |||||||||||||||||||||||
| Attributable to NCI: | 0 | ||||||||||||||||||||||
| Balance as of June 30, 2022 | $ | ( | $ | $ | $ | ( | |||||||||||||||||
| OCI before reclassifications | |||||||||||||||||||||||
| Amounts reclassified from AOCI | |||||||||||||||||||||||
| Net OCI | |||||||||||||||||||||||
| Balance as of September 30, 2022 | $ | ( | $ | $ | $ | ( | |||||||||||||||||
23
| (in millions) | Foreign Currency Translation | Ownership Share of Equity Method Investees’ OCI | Other | AOCI, Net | |||||||||||||||||||
| Attributable to Fluor: | |||||||||||||||||||||||
| Balance as of December 31, 2021 | $ | ( | $ | ( | $ | ( | $ | ( | |||||||||||||||
| OCI before reclassifications | ( | ( | ( | ||||||||||||||||||||
| Amounts reclassified from AOCI | ( | ||||||||||||||||||||||
| Net OCI | ( | ( | ( | ||||||||||||||||||||
| Balance as of September 30, 2022 | $ | ( | $ | ( | $ | ( | $ | ( | |||||||||||||||
| 0 | |||||||||||||||||||||||
| Attributable to NCI: | 0 | ||||||||||||||||||||||
| Balance as of December 31, 2021 | $ | ( | $ | $ | $ | ( | |||||||||||||||||
| OCI before reclassifications | |||||||||||||||||||||||
| Amounts reclassified from AOCI | |||||||||||||||||||||||
| Net other comprehensive income (loss) | |||||||||||||||||||||||
| Balance as of September 30, 2022 | $ | ( | $ | $ | $ | ( | |||||||||||||||||
The reclassifications out of AOCI follow:
| Location in Statement of Operations | 3ME September 30, | 9ME September 30, | ||||||||||||||||||||||||||||||
| (in millions) | 2023 | 2022 | 2023 | 2022 | ||||||||||||||||||||||||||||
| Component of AOCI: | ||||||||||||||||||||||||||||||||
| Ownership share of equity method investees’ OCI | Cost of revenue | $ | $ | $ | $ | ( | ||||||||||||||||||||||||||
| Income tax benefit | Income tax expense (benefit) | |||||||||||||||||||||||||||||||
| Net of tax | $ | $ | $ | $ | ( | |||||||||||||||||||||||||||
| Unrealized gain (loss) on foreign currency contracts | Cost of revenue | $ | $ | $ | ( | $ | ||||||||||||||||||||||||||
| Income tax benefit | Income tax expense (benefit) | |||||||||||||||||||||||||||||||
| Net of tax | $ | $ | $ | ( | $ | |||||||||||||||||||||||||||
24
FLUOR CORPORATION
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
The following discussion and analysis should be read in conjunction with our financial statements and our 2022 10-K. Except as the context otherwise requires, the terms Fluor or the Registrant, as used herein, are references to Fluor and references to the company, we, us, or our, as used herein, shall include Fluor, its consolidated subsidiaries and joint ventures.
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS
Certain statements made herein, including statements regarding our projected operating results, liquidity and backlog levels and the implementation of strategic initiatives are forward-looking in nature. Under the Private Securities Litigation Reform Act of 1995, a “safe harbor” may be provided to us for certain of these forward-looking statements. We caution readers that forward-looking statements, including disclosures which use words such as we “believe,” “anticipate,” “expect,” “estimate,” "aspire," "commit," "will," "may" and similar statements, are subject to risks and uncertainties which could cause actual results to differ materially from stated expectations. Significant factors potentially contributing to such differences include:
•The cyclical nature of many of the markets we serve and our clients' vulnerability to poor economic conditions, such as inflation, slow growth or recessions, which may result in decreased capital investment and reduced demand for our services;
•Our failure to receive anticipated new contract awards and the related impact on our operations;
•Failure to accurately estimate the cost and schedule on our projects, potentially resulting in cost overruns or obligations, including those related to project delays and those caused by the performance of our clients, subcontractors, suppliers and partners;
•Intense competition in the global EPC industry, which can place downward pressure on our contract prices and profit margins and may increase our contractual risks;
•The inability to hire and retain qualified personnel;
•Failure of our joint venture partners to perform their venture obligations, which could impact the success of those ventures and impose additional financial and performance obligations on us;
•Failure of our suppliers or subcontractors to provide supplies or services at the agreed-upon levels or times;
•Cybersecurity breaches of our systems and information technology;
•Civil unrest, security issues, labor conditions and other unforeseeable events in the countries in which we do business;
•Project cancellations, scope adjustments or deferrals, or foreign currency fluctuations, that could reduce the amount of our backlog and the revenue and profits that we earn;
•Repercussions of events beyond our control, such as severe weather conditions, natural disasters, pandemics, political crises or other catastrophic events, that may significantly affect operations, result in higher cost or subject the company to contract claims by our clients;
•Differences between our actual results and the assumptions and estimates used to prepare our financial statements;
•Client delays or defaults in making payments;
•The potential impact of changes in tax laws and other tax matters including, but not limited to, those from foreign operations, the realizability of our deferred tax assets and the ongoing audits by tax authorities;
•Our ability to secure appropriate insurance;
•The loss of business from one or more significant clients;
•The inability to adequately protect our intellectual property rights;
•The availability of credit and financial assurances plus restrictions imposed by credit facilities, both for us and our clients, suppliers, subcontractors or other partners;
•Adverse results in existing or future litigation, regulatory proceedings or dispute resolution proceedings (including claims for indemnification), or claims against project owners, subcontractors or suppliers;
•Failure of our employees, agents or partners to comply with laws, which could result in harm to our reputation and reduced profits or losses;
•The impact of new or changing legal requirements, as well as past and future environmental, health and safety regulations including climate change regulations; and
•The risks associated with acquisitions, dispositions or other investments, including the failure to successfully integrate acquired businesses.
Any forward-looking statements that we may make are based on our current expectations and beliefs concerning future developments and their potential effects on us. There is no assurance that future developments affecting us will be those presently anticipated by us.
Additional information concerning these and other factors can be found in our press releases and periodic filings with the SEC, including the 2022 10-K. These filings are available publicly on the SEC’s website at http://www.sec.gov, on our website at http://investor.fluor.com or upon request from our Investor Relations Department at (469) 398-7222. We cannot control such risk factors and other uncertainties, and in many cases, cannot predict the risks and uncertainties that could cause actual results to differ materially from those indicated by the forward-looking statements. These risks and uncertainties should be considered when evaluating Fluor and deciding whether to invest in our securities. Except as otherwise required by law, we undertake no obligation to publicly update or revise our forward-looking statements, whether as a result of new information, future events or otherwise.
Results of Operations
We have decided to retain Stork's North American operations, which largely consists of our operations and maintenance business owned by Fluor prior to our acquisition of Stork. Beginning in 2023, this business, renamed Plant & Facility Services, is included in our Urban Solutions segment for all periods presented.
In March 2023, we sold our AMECO South America business, which included operations in Chile and Peru. This transaction marked the completion of the AMECO divestiture for total proceeds of $144 million, including $17 million during the 2023 Period. Previous AMECO divestitures included assets in Africa, the Caribbean, Mexico and North America. Upon the sale of AMECO South America in the 2023 Period, we recognized a $60 million negative earnings impact, including $35 million associated with foreign currency translation.
In August 2023, we completed the issuance of the 2029 Notes, which is more fully described in the Liquidity and Capital Resources discussion.
In September 2023, we completed the conversion of all our CPS, which is more fully described in the Liquidity and Capital Resources discussion.
In 2021, we committed to achieving net zero emissions for Scopes 1 and 2 absolute greenhouse gas emissions by the end of 2023, and we believe we are on track to meet that objective.
| 3ME September 30, | 9ME September 30, | ||||||||||||||||||||||||||||||||||
| (in millions) | 2023 | 2022 | 2023 | 2022 | |||||||||||||||||||||||||||||||
| Revenue | |||||||||||||||||||||||||||||||||||
| Energy Solutions | $ | 1,553 | $ | 1,592 | $ | 4,886 | $ | 4,097 | |||||||||||||||||||||||||||
| Urban Solutions | 1,431 | 1,084 | 3,842 | 3,279 | |||||||||||||||||||||||||||||||
| Mission Solutions | 655 | 639 | 2,009 | 1,779 | |||||||||||||||||||||||||||||||
| Other | 324 | 297 | 917 | 879 | |||||||||||||||||||||||||||||||
| Total revenue | $ | 3,963 | $ | 3,612 | $ | 11,654 | $ | 10,034 | |||||||||||||||||||||||||||
| Segment profit (loss) $ and margin % | |||||||||||||||||||||||||||||||||||
| Energy Solutions | $ | 177 | 11.4% | $ | 59 | 3.7% | $ | 355 | 7.3% | $ | 177 | 4.3% | |||||||||||||||||||||||
| Urban Solutions | 66 | 4.6% | (50) | (4.6)% | 121 | 3.1% | (21) | (0.6)% | |||||||||||||||||||||||||||
| Mission Solutions | 38 | 5.8% | 29 | 4.5% | 84 | 4.2% | 115 | 6.5% | |||||||||||||||||||||||||||
| Other | (5) | NM | (7) | NM | (108) | NM | (18) | NM | |||||||||||||||||||||||||||
Total segment profit $ and margin %(1) | $ | 276 | 7.0% | $ | 31 | 0.9% | $ | 452 | 3.9% | $ | 253 | 2.5% | |||||||||||||||||||||||
| G&A | (56) | (30) | (177) | (146) | |||||||||||||||||||||||||||||||
| Impairment | — | — | — | 63 | |||||||||||||||||||||||||||||||
| Foreign currency gain (loss) | 23 | 34 | (62) | 51 | |||||||||||||||||||||||||||||||
Interest income (expense), net | 42 | 14 | 120 | 4 | |||||||||||||||||||||||||||||||
| Earnings (loss) attributable to NCI | (25) | (46) | (42) | (31) | |||||||||||||||||||||||||||||||
| Earnings before taxes | 260 | 3 | 291 | 194 | |||||||||||||||||||||||||||||||
| Income tax expense | (79) | (27) | (172) | (89) | |||||||||||||||||||||||||||||||
| Net earnings (loss) | $ | 181 | $ | (24) | $ | 119 | $ | 105 | |||||||||||||||||||||||||||
| Less: Net earnings (loss) attributable to NCI | (25) | (46) | (42) | (31) | |||||||||||||||||||||||||||||||
Net earnings attributable to Fluor | $ | 206 | $ | 22 | $ | 161 | $ | 136 | |||||||||||||||||||||||||||
| New awards | |||||||||||||||||||||||||||||||||||
| Energy Solutions | $ | 3,252 | $ | 3,574 | $ | 4,718 | $ | 5,595 | |||||||||||||||||||||||||||
| Urban Solutions | 1,033 | 933 | 5,090 | 3,549 | |||||||||||||||||||||||||||||||
| Mission Solutions | 345 | 4,874 | 1,015 | 5,312 | |||||||||||||||||||||||||||||||
| Other | 346 | 362 | 1,097 | 763 | |||||||||||||||||||||||||||||||
| Total new awards | $ | 4,976 | $ | 9,743 | $ | 11,920 | $ | 15,219 | |||||||||||||||||||||||||||
| New awards related to projects located outside of the U.S. | 65% | 48% | |||||||||||||||||||||||||||||||||
Backlog (in millions) | September 30, 2023 | December 31, 2022 | ||||||||||||
| Energy Solutions | $ | 9,159 | $ | 9,134 | ||||||||||
| Urban Solutions | 11,051 | 10,270 | ||||||||||||
| Mission Solutions | 4,563 | 5,666 | ||||||||||||
| Other | 1,231 | 979 | ||||||||||||
| Total backlog | $ | 26,004 | $ | 26,049 | ||||||||||
| Backlog related to projects located outside of the U.S. | 52% | 49% | ||||||||||||
| Backlog related to reimbursable projects | 70% | 63% | ||||||||||||
(1)Total segment profit is a non-GAAP financial measure. We believe that total segment profit provides a meaningful perspective on our results as it is the aggregation of individual segment profit measures that we use to evaluate and manage our performance.
While we experienced reductions in demand for certain services and the delay or abandonment of ongoing or anticipated projects during the COVID pandemic, our ability to win work was not materially impacted by COVID during the 2023 Period. Although many of our projects are in a state we consider normal, we continue to deal with the effects of COVID on our operating results as our estimates are inclusive of COVID effects and client recoveries.
During the 2023 Quarter and 2023 Period, consolidated revenue increased due to the ramp up of execution activities on several recently awarded projects in Energy Solutions, Urban Solutions and Mission Solutions partially offset by declines in the volume of execution activity for projects which were completed or nearing completion.
During the 2023 Quarter, segment profit significantly improved due to higher execution activity on new projects as well as the initial recognition of cost recovery entitlements on several fixed price projects and incentive fees on a mining project. Segment profit for the 2023 Period also improved despite a $59 million charge on the LAX Automated People Mover project, $58 million in charges on a legacy upstream project and a $60 million negative earnings impact upon the sale of our AMECO South America business.
We did not recognize any material impairment expense during the 2023 Period. During the 2022 Period, we reversed $63 million in impairment originally recognized in 2021 when our Stork and AMECO businesses were classified as held for sale, due primarily to remeasurement under held and used impairment criteria, for which CTA balances are excluded from carrying value.
The effective tax rate on earnings was 30.4% for the 2023 Quarter and 59.1% for the 2023 Period compared to 939.2% for the 2022 Quarter and 46.0% for the 2022 Period. A reconciliation of U.S. statutory federal income tax expense to income tax expense follows:
| 3ME September 30 | 9ME September 30 | ||||||||||||||||||||||
| (In millions) | 2023 | 2022 | 2023 | 2022 | |||||||||||||||||||
| U.S statutory federal income tax expense | $ | 55 | $ | 1 | $ | 61 | $ | 41 | |||||||||||||||
| Increase (decrease) in taxes resulting from: | |||||||||||||||||||||||
| State and local income taxes, net of federal income tax effects | 3 | 1 | 1 | 3 | |||||||||||||||||||
| Valuation allowance, net | 18 | 15 | 94 | 50 | |||||||||||||||||||
| Foreign tax impacts | (2) | — | 14 | (11) | |||||||||||||||||||
| Noncontrolling interest | 5 | 10 | 9 | 6 | |||||||||||||||||||
| Sale of AMECO South America | — | — | (10) | — | |||||||||||||||||||
| Other adjustments | — | — | 3 | — | |||||||||||||||||||
| Total income tax expense | $ | 79 | $ | 27 | $ | 172 | $ | 89 | |||||||||||||||
Backlog as of September 30, 2023 was stable with December 31, 2022. We recognize new awards into backlog when we and our client have approved the contract (written or verbal) and are committed to perform our respective obligations. Although backlog reflects business that is considered to be firm, cancellations, deferrals or scope adjustments may occur. Backlog is adjusted to reflect any known project cancellations, revisions to project scope and cost, foreign currency exchange fluctuations and project deferrals, as appropriate. Backlog differs from RUPO discussed elsewhere. RUPO includes only the amount of revenue we expect to recognize under contracts with definite terms and substantive termination provisions.
Segment Operations
Energy Solutions
Revenue in both the 2023 Quarter and 2023 Period benefitted from the initial recognition of revenue on cost recovery entitlements on several fixed price projects. Revenue in the 2023 Period further increased due to the ramp up of execution activities on our refinery projects in Mexico, chemicals projects in China and mid-scale LNG projects. These increases to revenue were partially offset by a decline in execution activity for projects nearing completion and lower revenue on an LNG project.
Segment profit for the 2023 Quarter and 2023 Period significantly improved primarily due to the initial recognition of cost recovery entitlements on several fixed price projects partially offset by cost growth on a large upstream legacy project and a charge for the expected net settlement of a longstanding claim. Segment profit for the 2023 Quarter also included a gain of $24 million on embedded foreign currency derivatives compared to a loss of $5 million in the 2022 Quarter. Segment profit for the 2023 Period included the ramp up of execution activities on the refinery projects in Mexico as well as the effects of favorable foreign currency remeasurement. The increases in segment profit margin in 2023 reflect these same factors.
New awards were slightly lower in 2023 compared to 2022 but included a confidential reimbursable EPCM contract for a large chemicals project in North America. Backlog remained flat during the 2023 Period.
Urban Solutions
Revenue in the 2023 Quarter and 2023 Period increased due to the ramp up of execution activities on several recently awarded projects including a large metals project in the U.S., two life sciences projects and a semiconductor project. The revenue increases in 2023 were partially offset by declines in the volume of execution activity for projects nearing completion including a large mining project.
Segment profit for the 2023 Quarter and 2023 Period significantly improved. Segment profit in the 2023 Quarter includes an incentive fee award on a large mining project that is nearing completion as well as a favorable arbitration outcome on a separate mining project whereas segment profit in the 2022 Quarter included charges related to cost growth and schedule delays on three legacy infrastructure projects. Segment profit in the 2023 Period includes a $59 million charge for rework associated with subcontractor design errors, related schedule impacts and system integration testing timelines on the LAX Automated People Mover project. The increases in segment profit margin in 2023 reflect these same factors.
New awards increased during the 2023 Quarter and 2023 Period. New awards booked during the 2023 Quarter included incremental awards on a life sciences project. Backlog increased during the 2023 Period due to the new award activity during 2023. Our staffing business does not report new awards or backlog.
Mission Solutions
Revenue increased in the 2023 Quarter and 2023 Period due to increased execution activities for FEMA hurricane support, the LOGCAP program in Africa and three DOE contracts. The increase in revenue was partially offset by the completion of a contingency and humanitarian support project in 2022 and close out activities for an airfield construction project and one DOE contract.
The improvement in segment profit in the 2023 Quarter was driven primarily by increased execution for FEMA hurricane support. Additionally, the 2022 Quarter included an incremental charge for cost growth on a weapons facility project. The decline in segment profit in the 2023 Period was substantially driven by a $30 million charge for cost growth associated with additional schedule delays on a weapons facility project. We are conducting our due diligence to recover cost growth that has resulted from directed and constructive changes from the client on the project. The decline in segment profit in the 2023 Period also reflects the completion of the contingency and humanitarian support project and the favorable resolution of an Army Corps of Engineers project in the 2022 Period. The changes to segment profit margin in 2023 reflect these same factors.
New awards decreased during the 2023 Quarter and 2023 Period due to a large award booked in the prior year for a 4-year contract extension on the DOE Savannah River Site. The decline in backlog during the 2023 Period resulted from work performed outpacing new award activity. Backlog included $3.0 billion and $3.9 billion of unfunded government contracts as of September 30, 2023 and December 31, 2022, respectively. Unfunded backlog reflects our estimate of future revenue under awarded government contracts for which funding has not yet been appropriated.
Other
Other includes the operations of NuScale, Stork and the remaining AMECO business prior to their sale.
| 3ME September 30, | 9ME September 30, | |||||||||||||||||||||||||
| (in millions) | 2023 | 2022 | 2023 | 2022 | ||||||||||||||||||||||
NuScale (1) | $ | (19) | $ | (15) | $ | (71) | $ | (44) | ||||||||||||||||||
| Stork | 14 | 4 | 25 | 16 | ||||||||||||||||||||||
| AMECO | — | 4 | (62) | 10 | ||||||||||||||||||||||
| Segment profit (loss) | $ | (5) | $ | (7) | $ | (108) | $ | (18) | ||||||||||||||||||
(1) NuScale expenses included in the determination of segment profit were as follows: | ||||||||||||||||||||||||||
| NuScale expenses | $ | (49) | $ | (47) | $ | (164) | $ | (110) | ||||||||||||||||||
| Less: DOE Reimbursable expenses | 17 | 25 | 43 | 56 | ||||||||||||||||||||||
| NuScale expenses, net | (32) | (22) | (121) | (54) | ||||||||||||||||||||||
| Less: Attributable to NCI | 13 | 7 | 50 | 10 | ||||||||||||||||||||||
| NuScale profit (loss) | $ | (19) | $ | (15) | $ | (71) | $ | (44) | ||||||||||||||||||
Segment profit in the 2023 Period includes the $60 million negative earnings impact upon the sale of our AMECO South America business, including $35 million for foreign currency translation.
G&A
| 3ME September 30, | 9ME September 30, | ||||||||||||||||||||||
| (in millions) | 2023 | 2022 | 2023 | 2022 | |||||||||||||||||||
| G&A | |||||||||||||||||||||||
| Compensation | $ | 45 | $ | 20 | $ | 123 | $ | 91 | |||||||||||||||
| SEC investigation | 2 | 1 | 12 | 13 | |||||||||||||||||||
| Reserve for legacy legal claims | — | — | 3 | 5 | |||||||||||||||||||
| Facilities | 4 | 4 | 11 | 12 | |||||||||||||||||||
| Exit costs | 2 | 1 | 9 | 5 | |||||||||||||||||||
| Other | 3 | 4 | 19 | 20 | |||||||||||||||||||
| G&A | $ | 56 | $ | 30 | $ | 177 | $ | 146 | |||||||||||||||
The increase in compensation expense in the 2023 Quarter was driven by higher performance-based compensation, including annual bonus projections in 2023, and higher stock-price-driven compensation due to the increase in our stock price from June 2023 to September 2023.
Net Interest Income (Expense)
The increase in net interest income during the 2023 Quarter and 2023 Period was due to an increase in interest rates earned on cash deposits including at our joint ventures in Canada and Mexico as well as the interest savings following the redemption of the 2023 Notes.
Critical Accounting Policies and Estimates
There have been no material changes in our critical accounting policies and estimates from those disclosed in our 2022 10-K.
Recent Accounting Pronouncements
Item is described more fully in the Notes to Financial Statements.
25
LIQUIDITY AND CAPITAL RESOURCES
Our liquidity arises from available cash and cash equivalents and marketable securities, cash generated from
operations, capacity under our credit facilities and, when necessary, access to capital markets. We have committed and uncommitted lines of credit available for revolving loans and letters of credit. We believe that for at least the next 12 months, anticipated cash generated from operations, along with our unused credit capacity and cash position, is sufficient to support operating requirements and debt maturities. We regularly review our sources and uses of liquidity and may pursue opportunities to address our liquidity needs, including to address our 2024 Notes' maturity.
Our credit facility contains provisions that will require us to provide collateral to secure the facility should we be downgraded to BB by S&P and Ba2 by Moody's, which is a one notch downgrade from both agencies' current ratings. If we are required to provide collateral, it would consist broadly of liens on our U.S. assets.
In August 2023, we issued $575 million of 1.125% Convertible Senior Notes due August 15, 2029 and received net proceeds of $560 million. Concurrently, we entered into capped call transactions with certain banks for $73 million. We believe the entry into the capped call transactions provides us with significant protection against the potential dilution associated with the 2029 Notes. In August 2023, we completed a tender offer in which we repurchased $115 million of outstanding 2024 Notes using the proceeds from the issuance of the 2029 Notes. Beginning in December 2023, we expect to begin a defeasance process to redeem all remaining outstanding 2024 Notes, but may also engage in market transactions ahead of that time to opportunistically redeem a portion of the 2024 Notes. In January 2023, we redeemed the remaining €129 million of outstanding 2023 Notes for $140 million using cash on hand.
As of September 30, 2023, letters of credit totaling $422 million were outstanding under our $1.8 billion credit facility, which matures in February 2026 and was amended in August 2023 to permit the issuance of the 2029 Notes. This credit facility contains customary financial covenants, including a debt-to-capitalization ratio that cannot exceed 0.60 to 1.00, a limitation on the aggregate amount of debt of the greater of $750 million or €750 million for our subsidiaries, and a minimum liquidity threshold of $1.5 billion, all as defined in the amended credit facility, which may be reduced to $1.0 billion upon the repayment of debt. Borrowings under the facility, which may be denominated in USD, EUR, GBP or CAD, bear interest at a base rate, plus an applicable borrowing margin. As of September 30, 2023 and through the issuance of this 10-Q, we had not made any borrowings under our credit facility and maintained a borrowing capacity of $797 million.
Cash and cash equivalents combined with marketable securities were $2.6 billion as of both September 30, 2023 and December 31, 2022. Cash balances as of September 30, 2023 and December 31, 2022 include cash and cash equivalents and marketable securities held by NuScale of $155 million and $338 million, respectively. Cash and cash equivalents are held in numerous accounts throughout the world to fund our global project execution activities. Non-U.S. cash and cash equivalents amounted to $1.1 billion as of both September 30, 2023 and December 31, 2022. Non-U.S. cash and cash equivalents exclude deposits of U.S. legal entities that are invested in offshore, overnight accounts or short-term time deposits, to which there is unrestricted access.
In evaluating our liquidity needs, we consider cash and cash equivalents held by our consolidated variable interest entities (joint ventures and partnerships). These amounts (which totaled $563 million and $706 million as of September 30, 2023 and December 31, 2022, respectively) were not necessarily readily available for general purposes. We do not include our share of cash held by our proportionately consolidated joint ventures and partnerships in our consolidated cash balances even though these amounts may be significant. We also consider the extent to which client advances (which totaled $95 million and $102 million as of September 30, 2023 and December 31, 2022, respectively) are likely to be sustained or consumed over the near term for project execution activities and the cash flow requirements of our various foreign operations. In some cases, it may not be financially efficient to move cash and cash equivalents between countries due to statutory dividend limitations and/or adverse tax consequences. We did not consider any cash to be permanently reinvested outside the U.S. as of September 30, 2023 and December 31, 2022, other than unremitted earnings required to meet our working capital and long-term investment needs in non-U.S. foreign jurisdictions where we operate.
26
Cash Flows
| 9ME September 30, | ||||||||||||||
| (in millions) | 2023 | 2022 | ||||||||||||
| OPERATING CASH FLOW | $ | (96) | $ | (15) | ||||||||||
| INVESTING CASH FLOW | ||||||||||||||
| Proceeds from sales and maturities (purchases) of marketable securities | 10 | (27) | ||||||||||||
| Capital expenditures | (71) | (38) | ||||||||||||
| Proceeds from sale of assets (including AMECO-South America in 2023) | 23 | 29 | ||||||||||||
| Investments in partnerships and joint ventures | (13) | (47) | ||||||||||||
| Other | 5 | 19 | ||||||||||||
| Investing cash flow | (46) | (64) | ||||||||||||
| FINANCING CASH FLOW | ||||||||||||||
| Proceeds from issuance of 2029 Notes, net of issuance costs | 560 | — | ||||||||||||
| Capped call transactions related to 2029 Notes | (73) | — | ||||||||||||
Proceeds from NuScale de-SPAC transaction | — | 341 | ||||||||||||
| Proceeds from sale of NuScale interest | — | 107 | ||||||||||||
| Purchases and retirement of debt | (249) | (23) | ||||||||||||
| Dividends paid on CPS | (29) | (29) | ||||||||||||
Make-whole payment on conversion of CPS | (27) | — | ||||||||||||
| Distributions to NCI (net of capital contributions) | (36) | (15) | ||||||||||||
| Other | (15) | (3) | ||||||||||||
| Financing cash flow | 131 | 378 | ||||||||||||
| Effect of exchange rate changes on cash | (7) | (72) | ||||||||||||
| Increase (decrease) in cash and cash equivalents | (18) | 227 | ||||||||||||
| Cash and cash equivalents at beginning of period | 2,439 | 2,209 | ||||||||||||
| Cash and cash equivalents at end of period | $ | 2,421 | $ | 2,436 | ||||||||||
| Cash paid during the period for: | ||||||||||||||
| Interest | $ | 46 | $ | 43 | ||||||||||
| Income taxes (net of refunds) | 129 | 71 | ||||||||||||
Operating Activities
Cash flows from operating activities result primarily from our EPC activities and are affected by our earnings level and changes in working capital associated with such activities. Working capital levels vary from period to period and are primarily affected by our volume of work and billing schedules on our projects. These levels are also impacted by the stage of completion and commercial terms of engineering and construction projects, as well as our execution of our projects compared to their budget. Working capital requirements also vary by project and the payments terms agreed to with our clients, vendors and subcontractors. Most contracts require payments as the projects progress. Additionally, certain projects receive advance payments from clients. A typical trend for our lump-sum projects is to have higher cash balances during the initial phases of execution due to deposits paid to us which then diminish toward the end of the construction phase. As a result, our cash position is reduced as customer advances are utilized, unless they are replaced by advances on other projects. We maintain cash reserves and borrowing facilities to provide additional working capital in the event that a project’s net operating cash outflows exceed its available cash balances. As of September 30, 2023, our backlog included $1.4 billion for loss projects which will impact our operating cash flow in future periods.
27
Our operating cash flow for the 2023 Period was negatively impacted by increases in working capital on several large projects and higher tax payments. We also funded an estimated $82 million on loss projects during the 2023 Period. Although earnings significantly improved during the 2023 Quarter, operating cash flow remained flat due to the increase in working capital. During the fourth quarter of 2023, we expect to receive cash settlements on certain project claims and disputes and cash distributions from one of our largest joint ventures as well as a potential tax refund.
Investing Activities
We hold cash in bank deposits and marketable securities which are governed by our investment policy. This policy focuses on, in order of priority, the preservation of capital, maintenance of liquidity and maximization of yield. These investments may include money market funds, bank deposits placed with highly-rated financial institutions, repurchase agreements that are fully collateralized by U.S. Government-related securities, high-grade commercial paper and high quality short-term and medium-term fixed income securities.
Capital expenditures in the 2023 and 2022 Periods were primarily related to construction equipment on certain infrastructure projects as well as expenditures for facilities and investments in IT.
Proceeds from sales of assets during the 2023 Period included $17 million for the sale of our AMECO South America business, which included operations in Chile and Peru. Proceeds from sales of assets during the 2022 Period included the sale of the majority of our interest in an infrastructure joint venture in Canada.
Investments in unconsolidated partnerships and joint ventures in the 2023 Period included capital contributions to a Mission Solutions joint venture and two infrastructure joint ventures. Investments in unconsolidated partnerships and joint ventures in the 2022 Period included capital contributions to a Mission Solutions joint venture and an infrastructure joint venture.
Financing Activities
In August 2023, we issued $575 million of 1.125% Convertible Senior Notes (the “2029 Notes”) due August 15, 2029 and received net proceeds of $560 million. Interest on the 2029 Notes is payable semi-annually on February 15 and August 15, beginning on February 15, 2024. The conversion rate for the 2029 Notes is 22.0420 shares of common stock per $1,000 principal amount of notes, which is equivalent to an initial conversion price of $45.37 per share. Holders may convert their 2029 Notes any time before May 2029 under the following conditions:
•if the last reported price of our common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter is greater than or equal to $58.98 on each applicable trading day;
•during the five-business day period after any five-consecutive trading day period in which the trading price of the 2029 Notes was less than 98% of the product of the last reported stock price and the conversion rate;
•if we call any or all of the 2029 Notes for redemption; or
•upon the occurrence of specified events as described in the applicable indenture.
In addition, holders may convert their 2029 Notes any time beginning on May 15, 2029 and prior to maturity without regard to the foregoing circumstances. Upon any conversion, we will repay the principal amount of the notes in cash and may elect to convey the conversion premium in any combination of cash and shares of our common stock. Certain events could cause the conversion rate to increase, including a make-whole fundamental change or redemption, but in no event will the conversion rate for a single note exceed 29.2056 shares of our common stock, other than for customary adjustments described in the applicable indenture.
After August 2026, we may elect to redeem up to all of the outstanding 2029 Notes if our common stock has a prevailing per share closing price in excess of $58.98. In such election, all principal would be settled in cash and could result in a make-whole premium if the holders also elect to convert. We may elect to pay any make-whole premium in any combination of cash and shares of our common stock.
In connection with the 2029 Notes offering, we entered into capped call transactions with certain banks. The strike price of the capped call options corresponds to the conversion price of the 2029 Notes of $45.37 per share. The capped call options are expected to offset potential dilution to our common stock upon conversion of any 2029 Notes and/or offset any cash payments we are required to make for any conversion premium if our stock price is greater than $45.37. The upper limit of the capped calls is $68.48 per share. If our stock price exceeds $68.48, there would be unmitigated dilution and/or no offset of any cash payments attributable to the amount by which our stock exceeds the cap price. We will not be required to make any cash payments to option counterparties upon the exercise of capped call options, but we will be entitled to receive from them shares of our common stock or an amount of cash based on the amount by which the market price of our common
28
stock exceeds the strike price of the capped calls. The capped call transactions are not part of the terms of the 2029 Notes and are accounted for as separate transactions. As the capped call options are indexed to our own stock, they are recorded in shareholders’ equity and are not accounted for as derivatives. The cost of the capped call transactions was $73 million which was recorded as a reduction to APIC, and will not be subject to periodic remeasurement.
In August 2023, we completed a tender offer in which we repurchased $115 million of outstanding 2024 Notes, excluding accrued interest, for consideration of $975.03 per $1,000 principal amount of the notes. In January 2023, we redeemed the remaining €129 million of outstanding 2023 Notes for $140 million. In June 2022, we redeemed €22 million of outstanding 2023 Notes for $23 million.
As a result of a reverse recapitalization, NuScale received cash of $341 million during the 2022 Period, consisting of $235 million in PIPE funding and $145 million in cash in trust, partially offset by transaction costs of $39 million. In April 2022, we sold approximately 5% of the ownership of NuScale to Japan NuScale Innovation, LLC for $107 million.
In September 2023, we exercised our mandatory conversion rights on our CPS in which all of the outstanding shares of CPS converted to 44.9585 shares of our common stock, plus a cash payment of $45.23 per CPS for a make-whole premium. The total make-whole premium amounted to $27 million, approximately $2 million less than the remaining undiscounted guaranteed dividend stream. First, second and third quarter CPS dividends of $10 million were paid in February, May and August 2023. Upon conversion, all dividends on the CPS have ceased. We have no obligation for accumulated but unpaid dividends since the last record date.
Distributions paid to holders of NCI represent cash outflows to partners of consolidated partnerships or joint ventures created primarily for the execution of single contracts or projects. Distributions in the 2023 Period related to a Mission Solutions joint venture and two infrastructure joint ventures. Distributions in the 2022 Period related to joint ventures in all our segments. Capital contributions by NCI during the 2023 Period related to investments by NuScale's NCI holders.
We have a common stock repurchase program, authorized by our Board of Directors, to purchase shares in the open market or privately negotiated transactions at our discretion. As of September 30, 2023, over 10 million shares could still be purchased under the existing stock repurchase program, although we do not have any immediate intent to begin such repurchases.
Letters of Credit
As of September 30, 2023, letters of credit totaling $422 million were outstanding under committed lines of credit. As of September 30, 2023, letters of credit totaling $920 million were outstanding under uncommitted lines of credit including letters of credit totaling $344 million for two lump-sum projects in Kuwait that are substantially complete except for the resolution of unapproved change orders and extension of time claims. Letters of credit are ordinarily provided to indemnify our clients if we fail to perform our obligations under our contracts. Surety bonds may be used as an alternative to letters of credit.
Guarantees
The maximum potential amount of future payments that we could be required to make under outstanding performance guarantees, which represents the remaining cost of work to be performed, was estimated to be $16 billion as of September 30, 2023.
Financial guarantees, made in the ordinary course of business in certain limited circumstances, are entered into with financial institutions and other credit grantors and generally obligate us to make payment in the event of a default by the borrower. These arrangements generally require the borrower to pledge collateral to support the fulfillment of the borrower’s obligation.
Item 3. Quantitative and Qualitative Disclosures about Market Risk
There have been no material changes to market risk during the 2023 Period. Accordingly, our disclosures provided in the 2022 10-K remain relevant.
29
Item 4. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
Based on their evaluation as of the end of the period covered by this report, our principal executive officer and principal financial officer have concluded that our disclosure controls and procedures (as defined in Rules 13a-15(e) or 15d-15(e) of the Exchange Act) are effective as required by paragraph (b) of Rule 13a-15 or Rule 15d-15 of the Exchange Act.
Changes in Internal Control over Financial Reporting
There were no changes to our ICFR that occurred during the period covered by this report that have materially affected, or are reasonably likely to materially affect, our ICFR.
30
FLUOR CORPORATION
CHANGES IN CONSOLIDATED BACKLOG
UNAUDITED
| 3ME September 30, | ||||||||||||||
| (in millions) | 2023 | 2022 | ||||||||||||
| Backlog, July 1 | $ | 25,483 | $ | 19,519 | ||||||||||
| New awards | 4,976 | 9,743 | ||||||||||||
| Adjustments and cancellations, net | (519) | (276) | ||||||||||||
| Work performed | (3,936) | (3,563) | ||||||||||||
| Backlog, September 30 | $ | 26,004 | $ | 25,423 | ||||||||||
| 9ME September 30, | ||||||||||||||
| (in millions) | 2023 | 2022 | ||||||||||||
| Backlog, January 1 | $ | 26,049 | $ | 20,800 | ||||||||||
| New awards | 11,920 | 15,219 | ||||||||||||
| Adjustments and cancellations, net | (404) | (711) | ||||||||||||
| Work performed | (11,561) | (9,885) | ||||||||||||
| Backlog, September 30 | $ | 26,004 | $ | 25,423 | ||||||||||
31
PART II: OTHER INFORMATION
Item 1. Legal Proceedings
As part of our normal business activities, we are party to a number of legal proceedings and other matters in various stages of development. Management periodically assesses our liabilities and contingencies in connection with these matters based upon the latest information available. We disclose material pending legal proceedings pursuant to SEC rules and other pending matters as we may determine to be appropriate.
Additional information on matters in dispute may be found in Part I, Item 1 of this Q3 2023 10-Q.
Item 1A. Risk Factors
Changes from our risk factors as disclosed in the 2022 10-K follow:
The capped call transactions may affect the value of the 2029 Notes and the market price of our common stock.
In connection with the pricing of the 2029 Notes, we entered into capped call transactions with the option counterparties.
The capped call transactions are expected generally to mitigate potential dilution to our common stock upon
conversion of any 2029 Notes and/or offset any cash payments we are required to make in excess of the principal amount of
converted 2029 Notes, subject to a cap.
After initially establishing their initial hedges of the capped call transactions, the option counterparties and/or their respective affiliates may modify their hedge positions by entering into or unwinding various derivatives with respect to our common stock and/or purchasing or selling our common stock or other securities of ours in secondary market transactions (and are
likely to do so on each exercise date for the capped call transactions or following any termination of any portion of
the capped call transactions in connection with any repurchase, redemption or early conversion of the 2029 Notes). This
activity could cause or avoid an increase or decrease in the market price of our common stock and/or the 2029 Notes, which
could affect an investor's ability to convert the 2029 Notes and, to the extent the activity occurs following conversion or during any observation period related to a conversion of 2029 Notes, it could affect the amount and value of the consideration that an investor will receive upon conversion of such 2029 Notes.
We are subject to counterparty risk with respect to the capped call transactions.
The option counterparties are financial institutions, and we will be subject to the risk that any or all of them might
default under the capped call transactions. Our exposure to the credit risk of the option counterparties will not be
secured by any collateral. Global economic conditions have resulted in the actual or perceived failure or financial
difficulties of several financial institutions and could adversely impact the option counterparties’ performance under
the capped call transactions. If an option counterparty becomes subject to insolvency proceedings, we could become
an unsecured creditor with a claim equal to our exposure at that time. Our exposure will depend on many factors but,
generally, an increase in our exposure will be correlated to an increase in the market price and in the volatility of our
common stock. In addition, upon a default by an option counterparty, we may suffer adverse tax consequences and/or
more dilution than we currently anticipate with respect to our common stock. We can provide no assurance as to the
financial stability or viability of the option counterparties.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
(c) The following table provides information for the quarter ended September 30, 2023 about purchases by the company of equity securities that have been registered pursuant to Section 12 of the Exchange Act.
32
Issuer Purchases of Equity Securities
| Period | Total Number of Shares Purchased | Average Price Paid per Share | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs | Maximum Number of Shares that May Yet Be Purchased Under the Plans or Program (1) | ||||||||||||||||||||||
| July 1 — July 31, 2023 | — | $ | — | — | 10,513,093 | |||||||||||||||||||||
| August 1 — August 31, 2023 | — | — | — | 10,513,093 | ||||||||||||||||||||||
| September 1 — September 30, 2023 | — | — | — | 10,513,093 | ||||||||||||||||||||||
| Total | — | $ | — | — | ||||||||||||||||||||||
_________________________________________________________
(1) The share repurchase program, as amended, totals 34,000,000 shares. We may repurchase shares from time to time in open market or privately negotiated transactions, including through pre-arranged trading programs, at our discretion, subject to market conditions and other factors and at such time and in amounts that we deem appropriate.
Item 4. Mine Safety Disclosures
None.
Item 5. Other Information
(c) Trading plans
33
Item 6. Exhibits
EXHIBIT INDEX
| Exhibit | Description | |||||||
| 3.1 | ||||||||
| 3.2 | ||||||||
| 4.1 | ||||||||
| 4.2 | ||||||||
| 10.1 | Amendment No. 1 to the Third Amended and Restated Revolving Credit Agreement, dated as of August 7, 2023, by and among Fluor Corporation, the lenders party thereto from time to time, and BNP Paribas, as administrative agent (incorporated by reference to Exhibit 10.1 to the registrant's Current Report on Form 8-K (Commission file number 1-16129) filed on August 11, 2023). | |||||||
| 10.2 | ||||||||
| 31.1 | ||||||||
| 31.2 | ||||||||
| 32.1 | ||||||||
| 32.2 | ||||||||
| 101.INS | Inline XBRL Instance Document.* | |||||||
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document.* | |||||||
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document.* | |||||||
| 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document.* | |||||||
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document.* | |||||||
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document.* | |||||||
| 104 | The cover page from the Company's Q3 2023 10-Q for the three and nine months ended September 30, 2023, formatted in Inline XBRL (included in the Exhibit 101 attachments).* | |||||||
_______________________________________________________________________
* New exhibit filed with this report.
34
SIGNATURES
Pursuant to the requirements of the Exchange Act, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| FLUOR CORPORATION | |||||||||||
| Date: | November 2, 2023 | By: | /s/ Joseph L. Brennan | ||||||||
| Joseph L. Brennan | |||||||||||
| Chief Financial Officer | |||||||||||
| Date: | November 2, 2023 | By: | /s/ John C. Regan | ||||||||
| John C. Regan | |||||||||||
| Chief Accounting Officer | |||||||||||
35